The Discounted Cash Flow (DCF) valuation of Korea Arlico Pharm Co Ltd (260660.KQ) is 10,450.16 KRW. With the latest stock price at 7,460.00 KRW, the upside of Korea Arlico Pharm Co Ltd based on DCF is 40.1%.
Based on the latest price of 7,460.00 KRW and our DCF valuation, Korea Arlico Pharm Co Ltd (260660.KQ) is a buy. buying 260660.KQ stocks now will result in a potential gain of 40.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.6% | 6.8% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 6,385.46 - 21,790.95 | 10,450.16 |
| Upside | -14.4% - 192.1% | 40.1% |